Literature DB >> 26563327

In Utero Diagnosis of Niemann-Pick Type C in the Absence of Family History.

E Colin1,2, M Barth3, F Boussion4, P Latour5, G Piguet-Lacroix5, A Guichet3, A Ziegler3, S Triau6, D Loisel7, L Sentilhes4, D Bonneau3,8.   

Abstract

Niemann-Pick type C (NPC) disease is a recessive disorder that results in unesterified cholesterol accumulating in the lysosomal and late endosomal system. It is caused by mutations in NPC1 or NPC2 genes and leads to systemic and neurodegenerative symptoms. Few cases of prenatal presentation of NPC have been reported and only two cases in the absence of previous family history, indicating the diagnosis is particularly difficult in such a situation. We report a prenatal diagnosis of NPC in a couple without family history. An ultrasound screening at 22 weeks of gestation (WG) detected fetal ascites and hepatomegaly, which were still present at 25, 27, and 29 WG, and a splenomegaly progressively appeared. No placentomegaly or other signs of hydrops fetalis were observed. The diagnostic of NPC was prenatally confirmed by a filipin test and NPC1 sequencing and multiplex ligation-dependent probe amplification assay which revealed a maternal missense mutation (c.2608T>C; p.Ser870Pro) and a paternal deletion of exons 5 to 25. This additional prenatal case of NPC suggests that even in the absence of family history, fetal ascites associated with splenomegaly but no hydrops should nonetheless arouse suspicion concerning this disease as a possible diagnosis.

Entities:  

Year:  2015        PMID: 26563327      PMCID: PMC5059189          DOI: 10.1007/8904_2015_516

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  10 in total

1.  Prenatal diagnosis of Niemann-Pick type C disease: current strategy from an experience of 37 pregnancies at risk.

Authors:  M T Vanier; C Rodriguez-Lafrasse; R Rousson; G Mandon; J Boué; A Choiset; M F Peyrat; C Dumontel; M C Juge; P G Pentchev
Journal:  Am J Hum Genet       Date:  1992-07       Impact factor: 11.025

2.  Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease.

Authors:  Forbes D Porter; David E Scherrer; Michael H Lanier; S Joshua Langmade; Vasumathi Molugu; Sarah E Gale; Dana Olzeski; Rohini Sidhu; Dennis J Dietzen; Rao Fu; Christopher A Wassif; Nicole M Yanjanin; Steven P Marso; John House; Charles Vite; Jean E Schaffer; Daniel S Ory
Journal:  Sci Transl Med       Date:  2010-11-03       Impact factor: 17.956

3.  Fetal ascites: an unusual presentation of Niemann-Pick disease type C.

Authors:  D J Manning; W I Price; R G Pearse
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

4.  Characterisation of two deletions involving NPC1 and flanking genes in Niemann-Pick type C disease patients.

Authors:  Laura Rodríguez-Pascau; Claudio Toma; Judit Macías-Vidal; Mónica Cozar; Bru Cormand; Lilia Lykopoulou; Maria Josep Coll; Daniel Grinberg; Lluïsa Vilageliu
Journal:  Mol Genet Metab       Date:  2012-10-14       Impact factor: 4.797

5.  Fetal ascites: an unusual presentation of Niemann-Pick disease type C.

Authors:  I K Maconochie; S Chong; G Mieli-Vergani; B D Lake; A P Mowat
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

Review 6.  Prenatal diagnosis of Niemann-Pick diseases types A, B and C.

Authors:  Marie T Vanier
Journal:  Prenat Diagn       Date:  2002-07       Impact factor: 3.050

Review 7.  Niemann-Pick disease type C.

Authors:  Marie T Vanier
Journal:  Orphanet J Rare Dis       Date:  2010-06-03       Impact factor: 4.123

8.  Prenatal-onset Niemann-Pick type C disease with nonimmune hydrops fetalis.

Authors:  Ozge Surmeli-Onay; Selin Yakarisik; Ayse Korkmaz; Zuhal Akcoren; Aysel Yuce; Heiko Runz; Miriam Stampfer; Murat Yurdakok
Journal:  Pediatr Neonatol       Date:  2013-03-11       Impact factor: 2.083

9.  The clinical spectrum of fetal Niemann-Pick type C.

Authors:  Ronen Spiegel; Annick Raas-Rothschild; Orit Reish; Miriam Regev; Vardiella Meiner; Ruth Bargal; Vivi Sury; Karen Meir; Michel Nadjari; Gratiana Hermann; Theodor C Iancu; Stavit A Shalev; Marsha Zeigler
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

10.  Prenatal revelation of Niemann-Pick disease type C in siblings.

Authors:  Rubén Moreno; Caroline Lardennois; Valérie Drouin-Garraud; Eric Verspyck; Stéphane Marret; Annie Laquerrière
Journal:  Acta Paediatr       Date:  2008-06-28       Impact factor: 2.299

  10 in total
  4 in total

1.  LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.

Authors:  Magali Pettazzoni; Roseline Froissart; Cécile Pagan; Marie T Vanier; Séverine Ruet; Philippe Latour; Nathalie Guffon; Alain Fouilhoux; Dominique P Germain; Thierry Levade; Christine Vianey-Saban; Monique Piraud; David Cheillan
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

2.  First Prenatal Diagnosis of a Niemann-Pick Disease Type C2 Revealed by a Cystic Hygroma: A Case Report and Review of the Literature.

Authors:  Liana Ples; Romina-Marina Sima; Florina Nedelea; Marius Moga
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-06       Impact factor: 5.555

3.  Transcriptome of HPβCD-treated Niemann-Pick disease type C1 cells highlights GPNMB as a biomarker for therapeutics.

Authors:  Jorge L Rodriguez-Gil; Laura L Baxter; Dawn E Watkins-Chow; Nicholas L Johnson; Cristin D Davidson; Steven R Carlson; Arturo A Incao; Kerri L Wallom; Nicole Y Farhat; Frances M Platt; Ryan K Dale; Forbes D Porter; William J Pavan
Journal:  Hum Mol Genet       Date:  2021-11-30       Impact factor: 5.121

4.  NPC1 Deficiency in Mice is Associated with Fetal Growth Restriction, Neonatal Lethality and Abnormal Lung Pathology.

Authors:  Jorge L Rodriguez-Gil; Dawn E Watkins-Chow; Laura L Baxter; Tadafumi Yokoyama; Patricia M Zerfas; Matthew F Starost; William A Gahl; May Christine V Malicdan; Forbes D Porter; Frances M Platt; William J Pavan
Journal:  J Clin Med       Date:  2019-12-19       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.